Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science ...
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...
Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...
Lung cancer cases are rising among non-smokers. Here's why the proportion is increasing, key causes, early signs, diagnosis, ...
The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...
Saudi Arabia's Food and Drug Authority grants conditional approval for Anktiva, a new cancer therapy for advanced lung and ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
While the statistics remain stark-lung cancer is the most common type of cancer worldwide and has the highest death ...
Bone metastases from pancreatic tumors are rare, representing less than 5% of all metastases [ 2 ]. Among these, only three ...
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to ...